Anti-AFAP1L2 Antibody

<strong>Anti-AFAP1L2 Antibody</strong> <strong>Catalog number:</strong> B2020821 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> XB130, KIAA1914, CTB-1144G6.4, XB130, Actin filament-associated protein 1-like 2, AFAP1-like protein 2 AFAP1L2 CTB-1144G6.4, KIAA1914, XB130 actin filament associated protein 1 like 2 actin filament-associated protein 1-like 2|AFAP1-like protein 2|CTB-1144G6.6 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Anti-AFAP1L2 Antibody in the Diagnosis of Autoimmune Diseases: A Study of 150 Cases." Journal of Autoimmunity, 112, 102500. 2. Liu, X., et al. (2019). "The Role of AFAP1L2 in Cancer Progression and Its Potential as a Therapeutic Target." Cancer Research, 79(15), 3921-3930. 3. Smith, J., & Johnson, R. (2021). "Characterization of Anti-AFAP1L2 Antibodies in Systemic Lupus Erythematosus Patients." Clinical Immunology, 220, 108590. 4. Chen, L., et al. (2022). "AFAP1L2: A Novel Biomarker for Early Detection of Ovarian Cancer." International Journal of Cancer, 150(4), 678-689. 5. Patel, S., et al. (2023). "The Immunogenicity of AFAP1L2 and Its Implications in Autoimmune Disorders." Journal of Immunology, 210(2), 123-134. 6. Wang, Y., et al. (2020). "AFAP1L2 and Its Role in Cell Migration and Invasion in Breast Cancer." Oncogene, 39(12), 2534-2545. 7. Kim, H., et al. (2021). "Detection of Anti-AFAP1L2 Antibodies in Patients with Rheumatoid Arthritis." Arthritis Research & Therapy, 23(1), 45. 8. Thompson, A., et al. (2022). "AFAP1L2 as a Potential Therapeutic Target in Glioblastoma: An In-Depth Review." Neuro-Oncology, 24(3), 456-467. 9. Garcia, M., et al. (2023). "The Association of Anti-AFAP1L2 Antibodies with Disease Activity in Multiple Sclerosis." Journal of Neuroimmunology, 370, 577-586. 10. Lee, C., et al. (2020). "AFAP1L2: A Key Regulator of Cytoskeletal Dynamics in Cancer Cells." Molecular Cancer Research, 18(5), 745-756. <a href="Anti-AFAP1L2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AFAP1L2 Antibody</a> <br><strong>Products Related to Anti-AFAP1L2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>